Variability of parvovirus B19 genotype 2 in plasma products with different compositions in the inactivation

M Tsujikawa1, H Nishigaki, M Yoshikawa

  • 1Osaka Research Laboratory, Research and Development Division, Benesis Corporation, Osaka, Japan. tsujikawa.muneo@mc.mt-pharma.co.jp

Vox Sanguinis
|July 26, 2011
PubMed
Abstract

Related Concept Videos